BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3608330)

  • 1. Pathologic fractures in a patient with renal osteodystrophy. Failure of early detection on bone scans.
    Campeau RJ; Bellah RD; Varma DG
    Clin Nucl Med; 1987 Jul; 12(7):510-3. PubMed ID: 3608330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal osteodystrophy.
    Parfitt AM
    Orthop Clin North Am; 1972 Nov; 3(3):681-98. PubMed ID: 4565585
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scan appearance of renal osteodystrophy in diabetic chronic renal failure patients.
    So Y; Hyun IY; Lee DS; Ahn C; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    Radiat Med; 1998; 16(6):417-21. PubMed ID: 9929141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migratory multiple bone involvement in a patient with systemic mastocytosis.
    Lidor C; Hallel T; Oren VO
    Clin Nucl Med; 1990 Sep; 15(9):640-3. PubMed ID: 2208886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periarticular bone sites associated with traumatic injury: false-positive findings with In-111-labeled white blood cell and Tc-99m MDP scintigraphy.
    Seabold JE; Ferlic RJ; Marsh JL; Nepola JV
    Radiology; 1993 Mar; 186(3):845-9. PubMed ID: 8430197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of bone scanning to detect fractures in a woman on chronic steroid therapy.
    Scott S; Alazraki N; Manaster B
    Skeletal Radiol; 1984; 12(3):204-7. PubMed ID: 6238410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of bone gammagraphy with Tc99-methyldiphosphonate (gamma G Tc99-MDP) in renal osteodystrophy].
    Garciá Garciá M; Vallés Prats M; López Pedret J; Pons Creus JM; Botey Puig A; Herranz G-Romero R; Setoain Quinquer J; Revert Torrellas L
    Rev Clin Esp; 1981 Apr; 161(1):31-5. PubMed ID: 6454934
    [No Abstract]   [Full Text] [Related]  

  • 8. Prominent Tc-99m MIBI skeletal uptake in renal osteodystrophy: a possible role for whole-body scanning.
    Reczek J; Elgazzar A
    Clin Nucl Med; 2003 Sep; 28(9):775-7. PubMed ID: 12973007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiophosphate imaging and bone densitometry in renal osteodystrophy.
    Rosenthall L
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):956-61. PubMed ID: 7922239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
    Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
    J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Delayed" appearance of positive bone scan following fracture.
    Skarzynski JJ; Sziklas JJ; Spencer RP
    Clin Nucl Med; 1985 Sep; 10(9):663-4. PubMed ID: 4064445
    [No Abstract]   [Full Text] [Related]  

  • 16. Recognition of renal osteodystrophy on bone imaging.
    Eggleston DE; Bartold K; Abghari R
    Clin Nucl Med; 1986 Aug; 11(8):543-4. PubMed ID: 3742909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor analysis of bone mineral dynamics in patients with renal osteodystrophy].
    Koizumi Y; Okamura T; Fukuda T; Inoue Y; Oomura M; Ikeda H; Hata M; Oda J; Ochi H; Onoyama Y
    Kaku Igaku; 1989 Jul; 26(7):829-34. PubMed ID: 2810901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
    Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
    Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum toxicity complicating renal osteodystrophy. A case report.
    Oppenheim WL; Namba R; Goodman WG; Salusky IB
    J Bone Joint Surg Am; 1989 Mar; 71(3):446-52. PubMed ID: 2925723
    [No Abstract]   [Full Text] [Related]  

  • 20. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.